{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:55:30Z","timestamp":1759010130162,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jinf.2011.11.028","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T23:20:09Z","timestamp":1324336809000},"page":"291-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis"],"prefix":"10.1016","volume":"64","author":[{"given":"Jann-Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Chung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan-Chyr","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2011.11.028_bib1","first-page":"1","article-title":"Recent advances in epidemiological research in tuberculosis","volume":"20","author":"Styblo","year":"1980","journal-title":"Adv Tuberc Res"},{"issue":"RR-11","key":"10.1016\/j.jinf.2011.11.028_bib2","first-page":"1","article-title":"Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.jinf.2011.11.028_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2011.11.028_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.jinf.2011.11.028_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jinf.2008.08.009","article-title":"Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment","volume":"58","author":"Kobashi","year":"2009","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jinf.2011.11.028_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09031936.00151309","article-title":"Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens","volume":"36","author":"Chee","year":"2010","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jinf.2011.11.028_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.rmed.2010.05.011","article-title":"Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy","volume":"104","author":"Bocchino","year":"2010","journal-title":"Respir Med"},{"issue":"4 Pt 2","key":"10.1016\/j.jinf.2011.11.028_bib8","first-page":"S221","volume":"161","author":"Anonymous","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2011.11.028_bib9","article-title":"Treatment of latent infection with M. tuberculosis: update 2010","author":"Leung","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jinf.2011.11.028_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council","volume":"145","author":"Anonymous","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.jinf.2011.11.028_bib11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1164\/ajrccm.154.5.8912767","article-title":"Rifampin preventive therapy for tuberculosis in Boston\u2019s homeless","volume":"154","author":"Polesky","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jinf.2011.11.028_bib12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1164\/ajrccm.155.5.9154885","article-title":"Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents","volume":"155","author":"Villarino","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"10.1016\/j.jinf.2011.11.028_bib13","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/archinte.166.17.1863","article-title":"Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study","volume":"166","author":"Page","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.jinf.2011.11.028_bib14","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1378\/chest.130.6.1712","article-title":"Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin","volume":"130","author":"Lardizabal","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jinf.2011.11.028_bib15","first-page":"160","article-title":"Successful use of rifampicin for Hispanic foreign-born patients with latent tuberculosis infection","volume":"12","author":"Haley","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.jinf.2011.11.028_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months","volume":"170","author":"Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jinf.2011.11.028_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"Menzies","year":"2008","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.jinf.2011.11.028_bib18","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"year":"2010","series-title":"Taiwan tuberculosis control report 2010","author":"Chang","key":"10.1016\/j.jinf.2011.11.028_bib19"},{"issue":"3","key":"10.1016\/j.jinf.2011.11.028_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2214\/AJR.07.3896","article-title":"Pulmonary tuberculosis: up-to-date imaging and management","volume":"191","author":"Jeong","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.jinf.2011.11.028_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jinf.2011.11.028_bib22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis","volume":"177","author":"Diel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jinf.2011.11.028_bib23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"Diel","year":"2007","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jinf.2011.11.028_bib24","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.jinf.2011.11.028_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jinf.2011.11.028_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","article-title":"Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis","volume":"174","author":"Ewer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jinf.2011.11.028_bib27","first-page":"1286","article-title":"Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts","volume":"12","author":"Franken","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9235","key":"10.1016\/j.jinf.2011.11.028_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jinf.2011.11.028_bib29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1086\/345760","article-title":"Tuberculin skin testing and in\u00a0vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii","volume":"186","author":"Arend","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2011.11.028_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3201\/eid1602.090675","article-title":"Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000\u20132008","volume":"16","author":"Lai","year":"2010","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311005986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311005986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:15:40Z","timestamp":1759007740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445311005986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0163445311005986"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2011.11.028","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-gamma release assay and Rifampicin therapy for household contacts of tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2011.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}